Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Oxaliplatin in Metastatic Colon Cancer
NCT00276861Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Sep 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine in colon cancer, sponsored by University of Miami. Primary endpoint: Response Rate as Measured by RECIST Criteria. Started Sep 2005; status: terminated.
02
Drugs
gemcitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00276861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276861.